Startups

Scientist II/Sr. Scientist I, Immunology

Antares Therapeutics · San Francisco, CA · On-site

← All jobs
About Antares Therapeutics

Backed by Atlas Venture.

About the role

We are seeking an immunologist with experience in autoimmune and inflammatory diseases (not I/O) who owns the biology. As a member of a highly integrated team of biologists, computational scientists and protein scientists, you will design, execute, and interpret the in vitro and ex vivo experiments that determine whether a target is tractable, whether a compound engages it in human cells, and whether that engagement produces the biology we intended. Found on 1752vc Careers, the job board for startup and VC roles.

More about this role

Job Summary

We are seeking an immunologist with experience in autoimmune and inflammatory diseases (not I/O) who owns the biology. As a member of a highly integrated team of biologists, computational scientists and protein scientists, you will design, execute, and interpret the in vitro and ex vivo experiments that determine whether a target is tractable, whether a compound engages it in human cells, and whether that engagement produces the biology we intended.

You will work in project teams and tackle the questions that determine program progression: is the cellular phenotype on-target, does the mechanism hold up in disease-relevant human systems, and what do the assay data tell us about whether to advance a series. Our research is focused on small-molecule modulation of immune signaling pathways that drive pathogenic inflammation, with the aim of achieving the selectivity and durability that current immunosuppressive approaches have not delivered.

The portfolio spans early target validation through IND-enabling studies, so you will see biology carried from first cellular proof of mechanism through to a development candidate. This is a hands-on individual-contributor role on the...

Read the full posting on Antares Therapeutics's site ↗

R&D

Build your edge while you search

Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.